<DOC>
	<DOCNO>NCT01630148</DOCNO>
	<brief_summary>The use prophylaxis venous thromboembolism ( VTE ) remain grossly underused woman undergo gynecologic surgery benign condition world wide especially develop country include region . Having research locality first time might raise awareness importance VTE prophylaxis .</brief_summary>
	<brief_title>Bemiparin Thromboprophylaxis After Gynaecological Surgeries</brief_title>
	<detailed_description>Deep vein thrombosis ( DVT ) pulmonary embolism ( PE ) , also refer venous thromboembolic event ( VTE ) , two major complication gynaecological surgery result significant morbidity mortality . The incidence VTE gynaecologic surgery varies depend method use diagnosis . The rate clinical DVT estimate 3 % gynaecological surgery thromboprophylaxis use . The rate VTE assume decrease 0.4 % Low molecular weight heparin use thromboprophylaxis . According knowledge publish research effect new second generation Low molecular Weight Heparin Bemiparin thromboprophylaxis benign gynaecological surgery comparison control group .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<criteria>female undergo Benign gynecological surgery . Having moderate , high high risk factor venous thromboembolism . No contraindication use Heparin . Having mild risk factor thromboembolism . Active vaginal bleeding . Thrombocytopaenia . patient already anticoagulant . Sever renal Liver disease .</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Thromboprophylaxis</keyword>
	<keyword>Bemiparin</keyword>
	<keyword>Low Molecular Weight Heparin</keyword>
	<keyword>Major Gynaecological Surgeries</keyword>
	<keyword>Benign Gynaecological Surgeries</keyword>
</DOC>